No Data
No Data
Guizhou Sanli (603439): Epitaxial mergers and acquisitions increase apparent growth rate, optimistic that the effects of integration will continue to be reflected
Matters: The company announced its 2023 annual report, achieving revenue of 1,635 million yuan (+36.10%), net profit of 293 million yuan (+45.42%), and net profit of 246 million yuan (+26.21%) after deduction
Guizhou Sanli (603439): Core product Kaiser continues to grow, merger and acquisition integration completes diversified layout
Event: On April 26, 2024, the company released the 2023 Annual Report and the First Quarter 2024 Report. In 2023, the company achieved revenue of 1,635 billion yuan, an increase of 36.10% over the previous year, in fact
Guizhou Sanli (603439.SH) reported 2023 annual results, with net profit of 293 million yuan, an increase of 45.42% over the previous year
Guizhou Sanli (603439.SH) released its 2023 annual report. During the reporting period, the company achieved operating income of 1,635 million yuan, an increase of 36.10%; net profit attributable to shareholders of listed companies of 293 million yuan, an increase of 45.42%; net profit attributable to shareholders of listed companies deducted 246 million yuan for non-recurring profit and loss, an increase of 26.21% over the previous year; and basic earnings per share of 0.71 yuan/share.
Declining Stock and Solid Fundamentals: Is The Market Wrong About Guizhou Sanli Pharmaceutical Co.,Ltd (SHSE:603439)?
Guizhou Sanli PharmaceuticalLtd (SHSE:603439) has had a rough three months with its share price down 22%. But if you pay close attention, you might gather that its strong financials could mean that
Guizhou Sanli Pharmaceutical Co.,Ltd (SHSE:603439) Shares Could Be 34% Below Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, Guizhou Sanli PharmaceuticalLtd fair value estimate is CN¥26.33 Guizhou Sanli PharmaceuticalLtd's CN¥17.31 share price signals that it might
Does Guizhou Sanli PharmaceuticalLtd (SHSE:603439) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' So it might be obvious
No Data